Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$7.49 USD
-0.01 (-0.13%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.48 -0.01 (-0.13%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -1.20 |
EPS Last Quarter | -0.89 |
Last EPS Surprise | 29.92% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.64 |
Next Year | -4.85 |
EPS (TTM) | -7.99 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.50M | 0.53M | 1.03M | 0.97M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.50M | 0.53M | 1.03M | 0.97M |
Low Estimate | 0.50M | 0.53M | 1.03M | 0.97M |
Year ago Sales | 0.00M | 0.00M | 3.60M | 1.03M |
Year over Year Growth Est. | NA | NA | -71.39% | -5.83% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.20 | -1.20 | -4.64 | -4.85 |
# of Estimates | 4 | 3 | 6 | 6 |
Most Recent Consensus | -1.29 | -1.34 | -4.52 | -4.78 |
High Estimate | -0.92 | -0.96 | -4.07 | -3.63 |
Low Estimate | -1.34 | -1.34 | -5.10 | -5.75 |
Year ago EPS | -3.30 | -2.30 | -11.60 | -4.64 |
Year over Year Growth Est. | 63.64% | 47.83% | 60.00% | -4.49% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 2 | 6 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.20 | -1.20 | -4.64 | -4.85 |
7 Days Ago | -1.20 | -1.20 | -4.64 | -4.85 |
30 Days Ago | -1.20 | -1.20 | -4.64 | -4.85 |
60 Days Ago | -1.17 | -1.21 | -5.50 | -5.18 |
90 Days Ago | -1.28 | -1.32 | -5.42 | -5.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.20 | -1.20 | -4.64 | -4.85 |
Zacks Consensus Estimate | -1.20 | -1.20 | -4.64 | -4.85 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.89 | -1.50 | -2.30 | -3.30 | NA |
Estimate | -1.27 | -1.28 | -2.80 | -3.00 | NA |
Difference | 0.38 | -0.22 | 0.50 | -0.30 | 0.09 |
Surprise | 29.92% | -17.19% | 17.86% | -10.00% | 5.15% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more